James C. Moon, MD

Clinical Director, Imaging
Barts Heart Centre and UCL
London, England, United Kingdom

James Moon is a Professor of Cardiology, University College London and clinical director of imaging, Barts Heart Centre, which serves a population of 6 million and performs 10,000 CMR, 7000 CT and 60,000 echos a year. He is a former member of NICE technology appraisal, past President of the British Society of Cardiovascular Magnetic Resonance, co-founder of LondonCMR, founder of the T1 mapping development group and ran the SCMR website for 5 years. His research groups interests are in heart muscle and the discovery/translation to clinical practice of imaging biomarkers for better care. He aims to observe rare and common disease, capturing causality to inform genetic and big data perspectives. He aims to move cardiology away from diseases definitions based on imaging morphology, to definitions based on pathways activated with novel biomarkers and therapies. His technical focus is on capturing signal from key processes (focal and diffuse fibrosis, iron, amyloid, fat with techniques including late gadolinium enhancement, T1 ECV and perfusion mapping) and transforming signal into data (AI approaches) and delivering them as globally quality controlled metrics for clinical care. This includes widening access for example - faster, cheaper, easier imaging in the developed world or MRI for pacemaker patients. He has 450 Pubmed papers. Google citations 40,000, h-index 95. Recipient of the 2021 SCMR gold medal. During COVID, he set up Covidsortium, the world's most informative granular mild disease study, publishing 3 Lancet, 3 Science and 1 Nature paper, generating 1200 global news articles and influencing global policies. Recently he founded Mycardium AI Ltd to bring superhuman AI to cardiology.

Disclosure information not submitted.

Presentation(s):

• 1338633 - Dark blood PSIR LGE with AI denoising speeds acquisition by 50%

  Wednesday, January 25, 2023

• 1342938 - Real-time Cine imaging with Convolutional Neural Network Transformer (CNNT) for Denoising

  Wednesday, January 25, 2023

• 1346611 - Optimal method of measuring LV mass: an AI test-retest study

  Wednesday, January 25, 2023

• 1351683 - Smooth and trabeculated left ventricular reference ranges on 4405 healthy subjects; integrating AI analysis with in-line deployment

  Wednesday, January 25, 2023

• 1355885 - Inclusion of papillary muscle mass and trabeculations in left ventricular assessment correlates more closely to total LVM in diseases of left ventricular hypertrophy.

  Wednesday, January 25, 2023

• 1357002 - Multiparametric SASHA combined T1 and T2 mapping: sex related differences and reference ranges at 1.5T

  Wednesday, January 25, 2023

• 1344149 - Global Myocardial Ischemia in Severe Aortic Stenosis Reverses Early after Aortic Valve Replacement

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1349395 - Correlations between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry disease.

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1349779 - Artificial Intelligence-measured MAPSE by CMR Unveils Early Left Ventricular Dysfunction in Aortic Stenosis and Predicts Worse Outcome

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1354976 - Prevalence of asymmetric septal hypertrophy (ASH) in hypertrophic cardiomyopathy (HCM) and mimics

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1356853 - Cardiovascular remodelling following treatment of primary aldosteronism – pathological insights from CMR.

  Thursday, January 26, 2023
  1:00 PM – 2:00 PM

• 1356800 - RAPID-Cardiotoxicity screening: image to report in 13 minutes

  Thursday, January 26, 2023
  3:00 PM – 3:10 PM

• 1357323 - A comparison of human and artificial-intelligence-based models to identify cardiotoxicity

  Thursday, January 26, 2023
  4:30 PM – 5:10 PM

• 1356594 - A Radiographer’s Evaluation of a Rapid Stress Perfusion CMR Protocol.

  Friday, January 27, 2023
  8:35 AM – 8:42 AM

• 1356971 - Waiting list backlog reduction with rapid scanning and AI-enabled reporting

  Friday, January 27, 2023
  9:50 AM – 10:00 AM

• 1342258 - Myocardial edema in aortic stenosis: insights from multiparametric SASHA

  Friday, January 27, 2023
  10:20 AM – 11:00 AM

• 1344061 - Rapid Myocyte Regression After Aortic Valve Replacement in Severe Aortic Stenosis

  Friday, January 27, 2023
  10:20 AM – 11:00 AM

• 1356119 - Advanced structural phenotype changes in hypertrophic cardiomyopathy from subclinical to overt disease: a 200-subject multicenter study

  Friday, January 27, 2023
  10:20 AM – 11:00 AM

• Talk #4 - Translation of AI tools into clinical practice

  Friday, January 27, 2023
  11:55 AM – 12:10 PM

• 1355246 - Discriminating hypertrophic cardiomyopathy (HCM) patients from healthy, athletic, and hypertensive patients using pure shape analysis

  Friday, January 27, 2023
  2:18 PM – 2:30 PM

• Moderating: Special Session (Non-CME)

  Friday, January 27, 2023
  1:30 PM – 2:30 PM

• 1395954 - Myocardial recovery and major adverse cardiovascular events following hospitalisation for COVID-19 with troponin elevation: longitudinal results from COVID-HEART, a UK prospective, multi-center study.

  Friday, January 27, 2023
  3:10 PM – 3:25 PM

• Gold Medal Award

  Friday, January 27, 2023
  6:15 PM – 6:35 PM

• Talk 2 - Collaboration With The Industry: Alternate Path: Phd And Clinicians

  Saturday, January 28, 2023
  8:15 AM – 8:30 AM

• Talk 2 - Read with the Experts #3 – CARDIOMYOPATHIES

  Saturday, January 28, 2023
  9:40 AM – 10:10 AM